ResMed, Inc. Share Price
Stocks
RMD
US7611521078
Advanced Medical Equipment & Technology
OTC Markets Traded|
Real-time Estimate
Cboe BZX
09:33:55 03/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 230.20 USD | -0.29% |
|
-2.63% | -4.70% |
| Market Cap | 3.33TCr 2.87TCr 2.71TCr 2.47TCr 4.61TCr 3,14600Cr 4.64TCr 32TCr 12TCr 1,60800Cr 13TCr 12TCr 5,28400Cr | P/E 2027 * |
20x | P/E 2028 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise Value | 3.23TCr 2.79TCr 2.63TCr 2.4TCr 4.48TCr 3,05600Cr 4.51TCr 31TCr 12TCr 1,56200Cr 12TCr 12TCr 5,13200Cr | EV / Sales 2027 * |
5.57x | EV / Sales 2028 * | 5.11x |
| Free-Float |
75.13% | Yield 2027 * |
1.15% | Yield 2028 * | 1.27% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| RMD | Delayed | |
CBOE
| RMD | Real-time | |
|
Mexican S.E.
| RMD * | End-of-day quote | |
|
Tradegate
| RME | Real-time | |
|
London S.E.
| 0KW4 | Delayed | |
|
Berne S.E.
| RME | End-of-day quote | |
|
Boerse Muenchen
| RME | Real-time | |
|
Deutsche Boerse AG
| RME | Delayed | |
|
Börse Stuttgart
| RME | Delayed | |
|
Wiener Boerse
| RMD | End-of-day quote | |
|
Borsa Italiana
| 1RMD | End-of-day quote |
Last Transcript : ResMed, Inc.
| 1 day | -0.30% | ||
| 1 week | -2.63% | ||
| Current month | -4.39% | ||
| 1 month | +6.68% | ||
| 3 months | +23.11% | ||
| 6 months | -11.12% | ||
| Current year | -4.70% |
| 1 week | 227.26 |  | 242.4 |
| 1 month | 202 | | 242.4 |
| Current year | 180.26 | | 277.67 |
| 1 year | 180.26 | | 284.87 |
| 3 years | 132.24 | | 293.81 |
| 5 years | 132.24 | | 301.34 |
| 10 years | 56.59 | | 301.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 53 | 01/03/2013 |
Aaron Bloomer
DFI | Director of Finance/CFO | 40 | 04/05/2026 |
| Chief Tech/Sci/R&D Officer | - | 01/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Ron Taylor
BRD | Director/Board Member | 78 | 01/01/2005 |
Mick Farrell
CHM | Chairman | 53 | 25/01/2023 |
Peter Farrell
CHM | Chairman | 83 | 01/06/1989 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 07/08/26 | Exercice | Chief Executive Officer | 14,973 | 0.0103% | ||
| 05/08/26 | Sell | Founder | -8,000 | 0.0055% | ||
| 07/07/26 | Exercice | Chief Executive Officer | 14,973 | 0.0103% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.29% | -2.63% | -14.73% | +49.17% | 3.33TCr | |
| +0.46% | -2.97% | +26.30% | +12.91% | 23TCr | |
| -0.55% | -2.88% | +5.03% | -19.70% | 15TCr | |
| -0.91% | +0.51% | -16.37% | +19.91% | 13TCr | |
| -2.56% | +1.34% | -56.02% | -11.27% | 7.01TCr | |
| -1.08% | -0.16% | +10.58% | +18.22% | 5.23TCr | |
| -1.65% | -1.15% | -16.82% | -14.83% | 5.09TCr | |
| -1.32% | -4.99% | +19.65% | +26.19% | 4.27TCr | |
| -0.16% | -2.24% | +41.98% | +49.02% | 4.05TCr | |
| -1.79% | -4.45% | -4.32% | +2.36% | 3.19TCr | |
| Average | -0.96% | -1.77% | -0.47% | +13.20% | 8.26TCr | |
| Weighted average by Cap. | -0.63% | -2.18% | +2.65% | +8.28% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 581.05Cr 501.27Cr 472.21Cr 430.24Cr 804.19Cr 55TCr 810.22Cr 5.59TCr 2.17TCr 28TCr 2.18TCr 2.13TCr 92TCr | 618.92Cr 533.95Cr 502.99Cr 458.28Cr 856.6Cr 58TCr 863.03Cr 5.95TCr 2.31TCr 30TCr 2.32TCr 2.27TCr 98TCr |
| Net income | 162.8Cr 140.45Cr 132.3Cr 120.54Cr 225.31Cr 15TCr 227Cr 1.57TCr 607.89Cr 7.86TCr 611.32Cr 597.95Cr 26TCr | 178.16Cr 153.7Cr 144.79Cr 131.92Cr 246.57Cr 17TCr 248.42Cr 1.71TCr 665.24Cr 8.6TCr 669Cr 654.37Cr 28TCr |
| Net Debt | -95Cr -82Cr -78Cr -71Cr -132.08Cr -9.02TCr -133.08Cr -918.22Cr -356.36Cr -4.61TCr -358.37Cr -350.54Cr -15TCr | -169.28Cr -146.03Cr -137.57Cr -125.34Cr -234.28Cr -16TCr -236.04Cr -1.63TCr -632.08Cr -8.18TCr -635.65Cr -621.75Cr -27TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | $229.53 | -0.58% | 1,62,986 |
| 02/26/02 | $230.87 | -0.21% | 11,56,476 |
| 01/26/01 | $231.36 | -3.64% | 9,87,078 |
| 31/26/31 | $240.10 | -0.10% | 17,22,128 |
| 28/26/28 | $240.33 | +1.94% | 13,86,748 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RMD Stock
Select your edition
All financial news and data tailored to specific country editions
